NEW YORK (GenomeWeb) – Medical diagnostics firm Alere today reported that its fourth quarter revenues fell 1 percent year over year, but increased 2 percent on an organic basis driven by strong international growth.

For the quarter ended Dec. 31, 2014, Alere reported revenue of $666.9 million compared to $673.2 million in Q4 2013, and ahead of the consensus analysts' estimate of $660.7 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.